A Novel Systems Pharmacology Method to Investigate Molecular Mechanisms of Scutellaria barbata D. Don for Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Novel Systems Pharmacology Method to Investigate Molecular Mechanisms of Scutellaria barbata D. Don for Non-small Cell Lung Cancer

Published:2018-12-17 Issue: Volume:9 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Liu Jianling,Jiang Meng,Li Zhihua,Zhang Xia,Li XiaoGang,Hao Yuanyuan,Su Xing,Zhu Jinglin,Zheng Chunli,Xiao Wei,Wang Yonghua

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference66 articles.

1. A natural flavonoid lawsonaringenin induces cell cycle arrest and apoptosis in HT-29 colorectal cancer cells by targeting multiple signalling pathways.;Anwar;Mol. Biol. Rep.,2018

2. Network biology: understanding the cell’s functional organization.;Barabási;Nat. Rev. Genet.,2004

3. Network analyses in systems pharmacology.;Berger;Bioinformatics,2009

4. Drug insight: vascular disrupting agents and angiogenesis–novel approaches for drug delivery.;Cooney;Nat. Clin. Pract. Oncol.,2006

5. Anti-angiogenic effect of the total flavonoids in Scutellaria barbata D. Don.;Dai;BMC Complement. Altern. Med.,2013

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Network pharmacology and transcriptomics reveal the mechanisms of FFBZL in the treatment of oral squamous cell carcinoma;Frontiers in Pharmacology;2024-09-11

2. Promising leads against lung cancer from the plants in Lamiaceae family;BioImpacts;2024-06-08

3. Revealing the therapeutic mechanism of Hedyotis diffusa-Sculellaria barbata in lung cancer through network pharmacology and molecular docking;2023-12-29

4. Blocking LTB4 signaling-mediated TAMs recruitment by Rhizoma Coptidis sensitizes lung cancer to immunotherapy;Phytomedicine;2023-10

5. Molecular Assessment of Scutellaria barbata D. Don in the Treatment of Nasopharyngeal Carcinoma Based on Network Pharmacology and Experimental Verification;Evidence-Based Complementary and Alternative Medicine;2022-02-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3